PSYENCE BIOMEDICAL LTD (PBM) Stock Price, Quote, News and Overview
NASDAQ:PBM - Nasdaq - CA74449F2098 - Common Stock - Currency: USD
PBM Quote, Performance and Key Statistics
4.4218
+0.02 (+0.5%)
The current stock price of PBM is 4.4218 USD. In the past month the price increased by 19.36%. In the past year, price decreased by -99.15%.
PBM Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 17.69 | 321.39B | ||
| AMGN | AMGEN INC | 13.09 | 146.07B | ||
| GILD | GILEAD SCIENCES INC | 12.96 | 124.92B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | N/A | 111.67B | ||
| REGN | REGENERON PHARMACEUTICALS | 13.2 | 63.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 36.86B | ||
| ARGX | ARGENX SE - ADR | 95.7 | 34.30B | ||
| ONC | BEIGENE LTD-ADR | 5.61 | 24.34B | ||
| BNTX | BIONTECH SE-ADR | N/A | 22.20B | ||
| NTRA | NATERA INC | N/A | 20.31B | ||
| BIIB | BIOGEN INC | 7.82 | 18.13B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 17.15B |
Related stock screener links
About PBM
Company Profile
Psyence Biomedical Ltd. is a life science biotechnology company. The company is headquartered in Toronto, Ontario. The company went IPO on 2021-12-10. The firm has partnered with iNGENu Pty Ltd (iNGENu) to conduct the Company’s clinical trial in palliative care. iNGENu is an Australia-based, globally focused contract research organization (CRO) with experience working in the psychedelic pharmaceutical drug development and clinical research industry. Its Phase IIb clinical trial, using PEX010, a 25mg naturally derived psilocybin drug candidate product in-licensed by the Company, in the palliative care setting.
Company Info
PSYENCE BIOMEDICAL LTD
121 Richmond Street West Penthouse, Suite 1300
TORONTO ONTARIO V6E 3Z3 CA
CEO: John Plourde
Employees: 0
Phone: 17744604171
PSYENCE BIOMEDICAL LTD / PBM FAQ
What is the stock price of PSYENCE BIOMEDICAL LTD today?
The current stock price of PBM is 4.4218 USD. The price increased by 0.5% in the last trading session.
What is the ticker symbol for PSYENCE BIOMEDICAL LTD stock?
The exchange symbol of PSYENCE BIOMEDICAL LTD is PBM and it is listed on the Nasdaq exchange.
On which exchange is PBM stock listed?
PBM stock is listed on the Nasdaq exchange.
What is PSYENCE BIOMEDICAL LTD worth?
PSYENCE BIOMEDICAL LTD (PBM) has a market capitalization of 20.03M USD. This makes PBM a Nano Cap stock.
How many employees does PSYENCE BIOMEDICAL LTD have?
PSYENCE BIOMEDICAL LTD (PBM) currently has 0 employees.
What are the support and resistance levels for PSYENCE BIOMEDICAL LTD (PBM) stock?
PSYENCE BIOMEDICAL LTD (PBM) has a support level at 3.69 and a resistance level at 4.78. Check the full technical report for a detailed analysis of PBM support and resistance levels.
Should I buy PSYENCE BIOMEDICAL LTD (PBM) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PBM, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PBM, evaluating the profitability, health, valuation and growth aspects
- PSYENCE BIOMEDICAL LTD (PBM) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PSYENCE BIOMEDICAL LTD (PBM) Sales and EPS estimates to see what analysts future expectations are.
- PSYENCE BIOMEDICAL LTD (PBM) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PSYENCE BIOMEDICAL LTD (PBM) Insider and Institutional Ownership to learn about the owners and their transactions.
- PSYENCE BIOMEDICAL LTD (PBM) Stock Chart to make your own analysis
- PSYENCE BIOMEDICAL LTD (PBM) Latest news and press-releases to stay up to date.
Does PSYENCE BIOMEDICAL LTD (PBM) stock pay dividends?
PBM does not pay a dividend.
PBM Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to PBM. When comparing the yearly performance of all stocks, PBM is a bad performer in the overall market: 99.03% of all stocks are doing better.
PBM Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |